Mark Hanna, | |
2300 M St Nw Fl 8, Washington, DC 20037-1434 | |
(202) 741-3003 | |
Not Available |
Full Name | Mark Hanna |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 8 Years |
Location | 2300 M St Nw Fl 8, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790147916 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Anne Arundel Medical Center | Annapolis, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Radiology Associates Inc | 5991692444 | 41 |
Community Radiology Associates Inc | 5991692444 | 41 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Entity Name | Medical Faculty Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Entity Name | Community Radiology Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396707782 PECOS PAC ID: 5991692444 Enrollment ID: O20040301000769 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Entity Name | Lenox Hill Radiology & Medical Imaging Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821036807 PECOS PAC ID: 2264424712 Enrollment ID: O20180328002687 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Entity Name | Hudson Valley Radiology Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174574115 PECOS PAC ID: 4486567690 Enrollment ID: O20191118001770 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Entity Name | Maryland Imaging Network Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487296471 PECOS PAC ID: 6103259304 Enrollment ID: O20221130002395 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mark Hanna, 2300 M St Nw Fl 8, Washington, DC 20037-1434 Ph: (202) 741-3003 | Mark Hanna, 2300 M St Nw Fl 8, Washington, DC 20037-1434 Ph: (202) 741-3003 |
News Archive
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. The results were published online last week in the American Journal of Clinical Oncology.
› Verified 3 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Dr. Michael B Shvarts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |